[1]
|
World Health Organization, 2013.
http://www.who.int/features/qa/15/en/index.html
|
[2]
|
“Instituto Nacional de Cancer Section of prostate cancer: Estimativa de incidência de Cancer no Brasil,” 2012.
http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/prostata
|
[3]
|
J. Fontenot, P. Taddei, Y. Zheng, D. Mirkovic, T. Jordan and W. Newhauser, “Equivalent Dose and Effective Dose from Stray Radiation during Passively Scattered Proton Radiotherapy for Prostate Cancer,” Physics in Medicine and Biology, Vol. 53, No. 6, 2008, pp. 1677-1688.
doi:10.1088/0031-9155/53/6/012
|
[4]
|
Y. Tao, D. Lefkopoulos, D. Ibrahima, A. Bridier, M. P. Polizzi, P. Wibault, R. Crevoisier, R. Arriagada and J. Bourhis, “Comparison of Dose Contribution to Normal Pelvic Tissues among Conventional, Conformal and Intensity-Modulated Radiotherapy Techniques in Prostate Cancer,” Acta Oncologica, Vol. 47, No. 3, 2008, pp. 442-450. doi:10.1080/02841860701666055
|
[5]
|
X. G. Xu, B. Bednarz and H. Paganetti, “A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction,” Physics in Medicine and Biology, Vol. 53 No. 13, 2008, pp. 193-241. doi:10.1088/0031-9155/53/13/R01
|
[6]
|
B. Bednarz and G. X. Xu, “Monte Carlo Modeling of a 6 and 18 MV Varian Clinac Medical Accelerator for In-Field and Out-of-Field Dose Calculations: Development and Validation,” Physics in Medicine and Biology, Vol. 54, No. 4, 2009, pp. 43-57.
|
[7]
|
D. J. Brenner, R. E. Curtis, E. J. Hall and E. Ron, “Second Malignancies in Prostate Carcinoma Patients after Radiotherapy Compared with Surgery Cancer,” Cancer, Vol. 88, No. 2, 2000, pp. 398-406.
|
[8]
|
M. W. Skwarchuk, A. Jackson, M. J. Zelefsky, E. S. Venkatraman, D. M. Cowen, S. Levegrün, C. M. Burman, Z. Fuks, S. A. Leibel and C. C. Ling, “Late Rectal Toxicity after Conformal Radiotherapy of Prostate Cancer (I): Multivariate Analysis and Dose-Response,” International Journal of Radiation Oncology, Biology, Physics, Vol. 47, No. 1, 2000, pp. 103-113.
doi:10.1016/S0360-3016(99)00560-X
|
[9]
|
S. L. Tucker, R. Cheung, L. Dong, H. H. Liu, H. D. Thames, E. H. Huang, D. Kuban and R. Mohan, “Dose-Volume Response Analyses of Late Rectal Bleeding after Radiotherapy for Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 59, No. 2, 2004, pp. 353-365. doi:10.1016/j.ijrobp.2003.12.033
|
[10]
|
K. Moon, G. J. Stukenborg, J. Keim and D. Theodorescu, “Cancer Incidence after Localized Therapy for Prostate Cancer,” Cancer, Vol. 107, No. 5, 2006, pp. 991-998.
doi:10.1002/cncr.22083
|
[11]
|
N. Baxter, J. E. Tepper, S. B. Durham, D. A. Rothenberger and B. A. Virnig, “Increased Risk of Rectal Cancer after Prostate Radiation: A Population-Based Study,” Gastroenterology, Vol. 128, No. 4, 2005, pp. 819-824.
doi:10.1053/j.gastro.2004.12.038
|
[12]
|
R. Kramer, J. W. Vieira, H. J. Khoury, F. R. A. Lima and D. Fuelle, “All about MAX: A Male Adult Voxel Phantom for Monte Carlo Calculations in Radiation Protection Dosimetry,” Physics in Medicine and Biology, Vol. 48, No. 10, 2003, pp. 1239-1262.
doi:10.1088/0031-9155/48/10/301
|
[13]
|
R. Jeraj, P. Keall and P. Ostwald, “Comparison between MCNP, EGS4, and Experiment for Clinical Electron Beams,” Physics in Medicine and Biology, Vol. 44, No. 3, 1999, pp. 705-717. doi:10.1088/0031-9155/44/3/013
|
[14]
|
D. B. Pelowitz, “MCNPXTM User’s Manual,” Version 2.5.0., Los Alamos National Laboratory Report 2005, LA-CP-05-0369.
|
[15]
|
A. M. Larcher, S. M. BonetDurán and A. M. Lerner, “Dosis Ocupacional Debida a Neutrons en Aceleradores Lineales de uso Medico,” Autoridad Regulatoria Nuclear Buenos Aires, 2000.
|
[16]
|
A. Facure, A. X. Silva and R. C. Falcao, “Monte Carlo Simulation of Scattered and Thermal Photoneutron fluences inside a Radiotherapy Room. Radiation Protection Dosimetry, Vol. 123, No. 1, 2007, pp. 56-61.
doi:10.1093/rpd/ncl080
|
[17]
|
W. F. Rebello, A. X. Silva and A. Facure, “Multileaf Shielding Design against Neutrons Produced by Medical Linear Accelerators,” Radiation Protection Dosimetry, 2008, Vol. 128, No. 2, pp. 227-233.
doi:10.1093/rpd/ncm312
|
[18]
|
A. J. Giordani, R. S. Dias, H. R. C. Segreto and R. A. Segreto, “Acurácia na Reprodutibilidade do Posicionamento diáRio de Pacientes Submetidos a Radioterapia Conformada (RT3D) para Cancer de próStata,” Radiologia Brasileira, Vol. 43, No. 4, 2010, pp. 236-240.
doi:10.1590/S0100-39842010000400007
|
[19]
|
S. C. A. Correa, E. M. Souza, A. X. Silva, H. Yoriyaz and R. T. Lopes, “AP and PA Thorax Radiographs: Dose Evaluation Using the FAX Phantom. International Journal of Low Radiation, Vol. 5, No. 3, 2008, pp. 237-255.
doi:10.1504/IJLR.2008.020253
|
[20]
|
S. C. A. Correa, E. M. Souza, A. X. Silva, H. Yoriyaz and R. T. Lopes, “Dose and Risk Evaluation in Thoracic Radiology Using Male and Female Voxels Phantom,” International Journal of Low Radiation, Vol. 7, No. 2, 2010, pp. 81-97. doi:10.1504/IJLR.2010.032812
|
[21]
|
S. C. A. Correa, J. O. Aquino, E. M. Souza and A. X. Silva, “Evaluation of the Dose and the Risk of Cancer Induction Associated with the Use of Transmission X-Ray Body Scanners Using the Monte Carlo MCNPX code,” International Journal of Low Radiation, Vol. 8, No. 5-6, 2011, pp. 340-354.
doi:10.1504/IJLR.2011.047180
|
[22]
|
International Commission on Radiological Protection, “The 2007 Recommendations of the International Commission on Radiological Protection,” Annals of the ICRP, 2007.
|
[23]
|
R. M. Howell, N. E. Hertel, Z. Wang, J. Hutchinson and G. Fullerton, “Calculation of Effective Dose from Measurements of Secondary Neutron Spectra and Scattered Photon Dose from Dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV Beam Energies,” Medical Physics, Vol. 33, No. 2, 2006, pp. 360-368. doi:10.1118/1.2140119
|